In an 87‑year‑old woman with chronic generalized pruritus and an unremarkable workup, what selective serotonin reuptake inhibitor (SSRI) or alternative medication can be used to treat her itching?

Treatment Recommendation for Chronic Pruritus in an 87-Year-Old Woman

For this 87-year-old patient with chronic generalized pruritus and negative workup, start with emollients and topical steroids for 2 weeks, then add gabapentin if symptoms persist; avoid sedating antihistamines entirely, and consider paroxetine or mirtazapine only if gabapentin fails.

Initial Management Approach

The British Association of Dermatologists 2018 guidelines provide specific algorithmic guidance for elderly patients with generalized pruritus of unknown origin (GPUO) 1:

First-line therapy (2-week trial):

• High lipid-content emollients applied liberally
• Topical steroids to treat potential asteatotic eczema (age-related dry skin)
• Self-care advice (keep nails short, avoid hot water, wear loose clothing)

Second-line therapy if initial treatment fails:

• Gabapentin is specifically recommended for elderly patients with pruritus (Strength of recommendation D; Level of evidence 3) 1
• A short course of non-sedating antihistamines (fexofenadine 180 mg or loratadine 10 mg) may be tried, though evidence is limited 1

Critical Safety Consideration for This Age Group

Sedating antihistamines should NOT be used in this 87-year-old patient (Strength of recommendation C; Level of evidence 2++) 1. The guidelines explicitly state that long-term sedative antihistamines may predispose to dementia and should be avoided except in palliative care 1.

SSRI Options if First-Line Treatments Fail

If emollients, topical steroids, and gabapentin prove inadequate, SSRIs can be considered for GPUO:

Recommended SSRIs based on guidelines:

• Paroxetine - specifically mentioned for GPUO and paraneoplastic pruritus 1
• Fluvoxamine - listed as an option for GPUO 1
• Sertraline - recommended for hepatic pruritus (third-line) 1

Alternative antidepressant:

• Mirtazapine - recommended for lymphoma-associated pruritus, paraneoplastic pruritus, and drug-induced pruritus 1

Evidence Supporting SSRIs

A 2009 open-label study of 72 patients (age range 28-88 years) demonstrated that paroxetine and fluvoxamine produced weak, good, or very good antipruritic effects in 68% of patients 2. The best responses occurred in atopic dermatitis, systemic lymphoma, and solid carcinoma. However, adverse effects occurred in 70.8% of patients, leading to discontinuation in 25% 2.

A 2017 systematic review concluded that oral antidepressants should be considered when pruritus is unresponsive to topical treatment and oral antihistamines, particularly for uremic, cholestatic, or paraneoplastic pruritus 3. A 2025 animal study provided mechanistic evidence that paroxetine suppresses both histamine-dependent and histamine-independent itch pathways 4.

Practical Treatment Algorithm

Step 1 (Weeks 1-2):

• Emollients with high lipid content + topical corticosteroid (e.g., clobetasone butyrate)
• Reassess after 2 weeks 1

Step 2 (if Step 1 fails):

• Add gabapentin (start low, titrate slowly given age)
• Consider non-sedating antihistamine trial (fexofenadine 180 mg daily)

Step 3 (if Steps 1-2 fail):

• Paroxetine (start 10 mg daily, can increase to 20 mg) OR
• Mirtazapine (start 7.5-15 mg at bedtime, useful if insomnia is present)

Step 4 (if all fail):

• Refer to dermatology for consideration of phototherapy (NB-UVB) or other specialized treatments
• Consider psychosocial evaluation if psychological factors suspected 1

Important Caveats

Before starting any systemic medication:

• Ensure complete workup has been done: CBC, comprehensive metabolic panel, liver function tests, thyroid function, chest X-ray to exclude occult malignancy 1
• Review all current medications for drug-induced pruritus 1
• Consider skin biopsy if bullous pemphigoid suspected (can present with pruritus alone in elderly) 1

SSRI considerations in elderly patients:

• Start at lower doses than in younger adults
• Monitor for hyponatremia (SIADH risk)
• Watch for falls risk, especially with paroxetine
• Be aware of drug interactions (paroxetine is a strong CYP2D6 inhibitor) 5
• Adverse effects led to discontinuation in 25% of patients in clinical studies 2
• Consider mirtazapine if sedation would be beneficial for concurrent insomnia

Why not start with SSRIs immediately: The guidelines clearly prioritize a stepwise approach starting with topical therapy and gabapentin before SSRIs 1. This is appropriate given the higher side effect burden of SSRIs in elderly patients and the specific evidence supporting gabapentin in this age group.